Patents by Inventor Matthew David Tandy

Matthew David Tandy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL FORMULATIONS FOR TREATING DISEASES ASSOCIATED WITH VOLTAGE-GATED SODIUM CHANNELS
    Publication number: 20230404913
    Abstract: Provided herein are certain pharmaceutical compositions comprising (S)-4-((1-benzylpyrrolidin-3-yl)(methyl)amino)-2-fluoro-5-methyl-N-(thiazol-4-yl)benzene-sulfonamide (Compound A), or a pharmaceutically acceptable salt thereof, and at least one pharmaceutically acceptable excipient. The pharmaceutical compositions can be present in form of an immediate release tablet, a granular formulation, a stable suspension oral dosage form or a multi-particulate sprinkle dosage form. Methods for the treatment of a disease or a condition associated with Naj4.6 activity, such as epilepsy, are described.
    Type: Application
    Filed: April 9, 2021
    Publication date: December 21, 2023
    Inventors: Jean-Jacques Alexandre Cadieux, Matthew David Tandy
  • SOLID STATE FORMS OF A SELECTIVE POTASSIUM CHANNEL MODULATOR
    Publication number: 20220064120
    Abstract: The present disclosure provides solid state forms of a selective potassium channel modulator and pharmaceutical compositions comprising the solid state crystalline forms and pharmaceutically acceptable excipients, and methods for preparing and using the solid state forms and the pharmaceutical compositions thereof.
    Type: Application
    Filed: July 6, 2021
    Publication date: March 3, 2022
    Applicant: Xenon Pharmaceuticals Inc.
    Inventors: Paul Robert BICHLER, Jean-Jacques Alexandre CADIEUX, Matthew David TANDY, Gregory N. BEATCH
  • Solid state crystalline forms of a selective potassium channel modulator
    Patent number: 11091441
    Abstract: The present disclosure provides solid state forms of a selective potassium channel modulator and pharmaceutical compositions comprising the solid state crystalline forms and pharmaceutically acceptable excipients, and methods for preparing and using the solid state forms and the pharmaceutical compositions thereof.
    Type: Grant
    Filed: October 13, 2020
    Date of Patent: August 17, 2021
    Assignee: Xenon Pharmaceuticals Inc.
    Inventors: Paul Robert Bichler, Jean-Jacques Alexandre Cadieux, Matthew David Tandy, Gregory N. Beatch
  • PEDIATRIC IMMEDIATE-RELEASE FORMULATION OF THE POTASSIUM CHANNEL OPENER EZOGABINE
    Publication number: 20210169839
    Abstract: Disclosed herein are immediate-release oral pharmaceutical formulations comprising a therapeutically effective amount of ezogabine and one or more pharmaceutically acceptable excipients for use in treating epilepsy and/or epileptic seizure disorders in a mammal, preferably a human, more preferably a child. Also disclosed are methods of using and making the immediate-release oral pharmaceutical formulations.
    Type: Application
    Filed: December 2, 2020
    Publication date: June 10, 2021
    Inventors: Jean-Jacques Alexandre Cadieux, Matthew David Tandy
  • SOLID STATE CRYSTALLINE FORMS OF A SELECTIVE POTASSIUM CHANNEL MODULATOR
    Publication number: 20210147363
    Abstract: The present disclosure provides solid state forms of a selective potassium channel modulator and pharmaceutical compositions comprising the solid state crystalline forms and pharmaceutically acceptable excipients, and methods for preparing and using the solid state forms and the pharmaceutical compositions thereof.
    Type: Application
    Filed: October 13, 2020
    Publication date: May 20, 2021
    Applicant: Xenon Pharmaceuticals Inc.
    Inventors: Paul Robert BICHLER, Jean-Jacques Alexandre CADIEUX, Matthew David TANDY, Gregory N. BEATCH
  • Co-crystals
    Patent number: 8592472
    Abstract: The present invention relates to co-crystals of propiconazole and a co-crystal forming compound.
    Type: Grant
    Filed: September 22, 2009
    Date of Patent: November 26, 2013
    Assignee: Syngenta Limited
    Inventors: James Owen Forrest, Neil George, Rebecca Claire Burton, Manish Maheshbhai Parmar, Matthew David Tandy, Suzanne Marie Buttar, Christopher Stephen Frampton, Adrian St Clair Brown, Alan Patrick Chorlton
  • CO-CRYSTALS
    Publication number: 20110245306
    Abstract: The present invention relates to co-crystals of propiconazole and a co-crystal forming compound.
    Type: Application
    Filed: September 22, 2009
    Publication date: October 6, 2011
    Applicant: SYNENTA CROP PROTECTION, INC.
    Inventors: James Owen Forrest, Neil George, Rebecca Claire Burton, Manish Maheshbhai Parmar, Matthew David Tandy, Suzanne Marie Buttar, Christopher Stephen Frampton, Adrian St. clair Brown, Alan Patrick Chorlton